Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts. (Q45181056)
Jump to navigation
Jump to search
scientific article published in February 1986
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts. |
scientific article published in February 1986 |
Statements
Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts (English)
Myers CL
Weiss SJ
Kirsh MM
Shepard BM
1 February 1986